POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 19 17:20 ET
Ensysce Biosciences | EFFECT: Others
Apr 8 06:07 ET
Ensysce Biosciences | 8-K: Current report
Mar 29 08:02 ET
Ensysce Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mar 26 16:46 ET
Ensysce Biosciences | 10-K: Annual report
Mar 15 12:35 ET
Ensysce Biosciences | 8-K: Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 15 08:15 ET
Ensysce Biosciences | D: Filing D
Feb 21 11:42 ET
Ensysce Biosciences | 424B3: Prospectus
Feb 15 12:22 ET
Ensysce Biosciences | 8-K: Current report
Feb 14 17:35 ET
Ensysce Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(3.792%),Lincoln Park Capital, LLC(3.792%), etc.
Feb 14 16:39 ET
Ensysce Biosciences | 424B3: Prospectus
Feb 14 06:07 ET
Ensysce Biosciences | S-1: General form for registration of securities under the Securities Act of 1933
Jan 17 00:00 ET
Ensysce Biosciences | 8-K: Current report
Dec 29, 2023 00:00 ET
Ensysce Biosciences | DEFA14A: Others
Dec 19, 2023 16:27 ET
Ensysce Biosciences | 8-K: Current report
Dec 19, 2023 16:24 ET
Ensysce Biosciences | RW: Registration Withdrawal Request
Nov 30, 2023 14:37 ET
Ensysce Biosciences | 8-K: Current report
Nov 29, 2023 09:24 ET
Ensysce Biosciences | EFFECT: Others
Nov 22, 2023 00:15 ET
Ensysce Biosciences | CORRESP: CORRESP
Nov 20, 2023 12:47 ET
Ensysce Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Nov 17, 2023 17:19 ET
No Data
No Data